Detalles de la búsqueda
1.
Do people with type 2 diabetes find continuous and intermittent low-energy diets for weight loss and diabetes remission acceptable?
J Hum Nutr Diet
; 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38798236
2.
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer.
Br J Cancer
; 126(8): 1157-1167, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34912072
3.
Manchester Intermittent versus Daily Diet App Study (MIDDAS): A pilot randomized controlled trial in patients with type 2 diabetes.
Diabetes Obes Metab
; 24(3): 432-441, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726317
4.
Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials.
BMC Cancer
; 19(1): 1089, 2019 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31795966
5.
Manchester Intermittent and Daily diet Type 1 Diabetes App Study (MIDDAS-Type 1): protocol for a randomised feasibility trial of an intermittent and continuous low-energy diet in patients with type 1 diabetes and overweight and obesity.
BMJ Open
; 13(7): e071395, 2023 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37474169
6.
Intermittent Versus Continuous Low-Energy Diet in Patients With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial.
JMIR Res Protoc
; 10(3): e21116, 2021 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33739297
7.
Testing a breast cancer prevention and a multiple disease prevention weight loss programme amongst women within the UK NHS breast screening programme-a randomised feasibility study.
Pilot Feasibility Stud
; 7(1): 220, 2021 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34930478
8.
Predictors of weight gain in a cohort of premenopausal early breast cancer patients receiving chemotherapy.
Breast
; 45: 1-6, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30802821
Resultados
1 -
8
de 8
1
Próxima >
>>